These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7856587)

  • 1. Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers.
    Barthes DM; Rochard EB; Pouliquen IJ; Rabouan SM; Courtois PY
    Am J Hosp Pharm; 1994 Nov; 51(21):2706-9. PubMed ID: 7856587
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
    Wolfe JL; Thoma LA; Du C; Goldspiel BR; Gallelli JF; Grimes GJ; Potti GK
    Am J Health Syst Pharm; 1999 May; 56(10):985-9. PubMed ID: 10365723
    [No Abstract]   [Full Text] [Related]  

  • 3. Physical and chemical stability of paclitaxel infusions in different container types.
    Donyai P; Sewell GJ
    J Oncol Pharm Pract; 2006 Dec; 12(4):211-22. PubMed ID: 17156593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection.
    Belliveau PP; Nightingale CH; Quintiliani R
    Am J Hosp Pharm; 1994 Apr; 51(7):901-4. PubMed ID: 8017440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinevac stability after reconstitution with sodium chloride injection USP, 0.9%.
    Littleton LT; Fileta BB; Massey R; Wood TI
    J Nucl Med Technol; 2009 Mar; 37(1):57-9. PubMed ID: 19223430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection.
    Belliveau PP; Shea BF; Scavone JM
    Am J Hosp Pharm; 1993 May; 50(5):950-2. PubMed ID: 8506875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of 99Tcm-MAG3: no confirmation that sodium chloride injections from plastic containers affect radiochemical purity.
    Millar AM; O'Brien LM
    Nucl Med Commun; 1998 May; 19(5):475-7. PubMed ID: 9853337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leaching of diethylhexyl phthalate from polyvinyl chloride materials into etoposide intravenous solutions.
    de Lemos ML; Hamata L; Vu T
    J Oncol Pharm Pract; 2005 Dec; 11(4):155-7. PubMed ID: 16595068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32 degrees C.
    Xu Q; Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Dec; 51(24):3058-60. PubMed ID: 7856626
    [No Abstract]   [Full Text] [Related]  

  • 12. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
    Yuan P; Grimes GJ; Shankman SE; Daniels CE; Goldspiel BR; Potti GK
    Am J Health Syst Pharm; 2001 Apr; 58(7):594-8. PubMed ID: 11296609
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of etoposide solution for oral use.
    McLeod HL; Relling MV
    Am J Hosp Pharm; 1992 Nov; 49(11):2784-5. PubMed ID: 1471649
    [No Abstract]   [Full Text] [Related]  

  • 14. Compatibility study of 5-fluorouracil with PVC bags after repackaging into two types of infusion admixtures.
    Benaji B; Faouzi MA; Dine T; Goudaliez F; Luyckx M; Brunet C; Kablan J; Gressier B; Cazin M; Cazin JC
    Therapie; 1999; 54(5):659-63. PubMed ID: 10667105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug precipitation and peristaltic pumps.
    Woloschuk DM
    Am J Hosp Pharm; 1994 Jun; 51(11):1473. PubMed ID: 7942882
    [No Abstract]   [Full Text] [Related]  

  • 17. Etoposide in continuous infusion: practical recommendations for pediatric protocols.
    Bauters T; Vandenbroucke J; Moerloose BD; Porre JD; Benoit Y; Robays H
    J Oncol Pharm Pract; 2011 Dec; 17(4):453-5. PubMed ID: 22130773
    [No Abstract]   [Full Text] [Related]  

  • 18. Stability of cyclosporine diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in ethylene-vinyl acetate containers.
    Li M; Coursol C; Leclair G
    Am J Health Syst Pharm; 2013 Nov; 70(22):1970-2. PubMed ID: 24173005
    [No Abstract]   [Full Text] [Related]  

  • 19. Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate.
    Sadou Yayé H; Hassani L; Secrétan PH; Babiard M; Aouati H; Bellanger A; Tilleul P; Yagoubi N; Do B; Rietveld IB
    J Pharm Biomed Anal; 2020 Jan; 178():112896. PubMed ID: 31600662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of midazolam hydrochloride in 5% dextrose injection or 0.9% sodium chloride injection over 30 days.
    Hagan RL; Jacobs LF; Pimsler M; Merritt GJ
    Am J Hosp Pharm; 1993 Nov; 50(11):2379-81. PubMed ID: 8266971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.